Interview with Professor Teresa Jackowska, president of the Polish Pediatric Society, conducted during the Congress on Child and Adolescent Health
RS virus is dangerous especially for young children. For which groups of children is prophylaxis available at this time?
For several years, a monoclonal antibody has been used in Poland for prevention: palivizumab. It passively prevents infections with the respiratory syncytial virus, which we call RS for short. Covered by this prophylaxis are very important risk groups, namely premature babies, as well as children with bronchopulmonary dysplasia. Since September of this year, thi...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
